Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Martha D. Port"'
2
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial
Autor: Chad Stroud, David Dolezil, Russell M Nichols, Martha D. Port, Austin Hand, Uwe Reuter, Antje Tockhorn-Heidenreich, Holland C. Detke, Christian Lucas
Publikováno v: Advances in Therapy
Introduction Results from the open-label extension of the phase 3b CONQUER trial are presented to evaluate the effectiveness and safety of galcanezumab, a monoclonal antibody targeting calcitonin gene-related peptide, for up to 6 months in patients w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf6676baa9eea3c271f82302e462775
http://europepmc.org/articles/PMC8523004
Zobrazit plný text záznamu
3
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
Autor: Mallikarjuna Rettiganti, Martha D. Port, Janet H. Ford, David W. Ayer, Tobias Kurth, Linda Wietecha, Amaal J. Starling, Dustin D. Ruff
Publikováno v: Headache
Objective This post hoc study investigated the relationship between patient response in terms of migraine headache day reduction and patient‐reported outcomes of health‐related quality of life (HRQoL) and disability categories. Background Migrain
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6c9e76eefa34edc6fc472fbd37bc5b
https://doi.org/10.1111/head.14013
Zobrazit plný text záznamu
4
Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex
Autor: Martha D. Port, Neil M. Nathanson, Robin M. Gibson
Publikováno v: Journal of Neurochemistry. 101:782-793
Leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) are cytokines which signal through receptor complexes that include the receptor subunits glycoprotein 130 (gp130) and the LIF receptor (LIFR), but CNTF also requires the non-sign
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eb3e3e84af87bf63c6b5ca20e317f570
https://doi.org/10.1111/j.1471-4159.2007.04471.x
Zobrazit plný text záznamu
5
Transregulation of Leukemia Inhibitor Factor Receptor Expression and Function by Growth Factors in Neuroblastoma Cells
Autor: Martha D. Port, George S. Laszlo, Neil M. Nathanson
Publikováno v: Journal of Neurochemistry.
The cytokines that signal through the leukemia inhibitory factor (LIF) receptor are members of the neuropoietic cytokine family and have varied and numerous roles in the nervous system. In this report we have determined the effects of growth factor s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1cb98e2eb02a7bca6728d6bbe23c1ff
https://doi.org/10.1111/j.1471-4159.2008.05535.x
Zobrazit plný text záznamu
6
Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex
Autor: Martha D, Port, Robin M, Gibson, Neil M, Nathanson
Publikováno v: Journal of neurochemistry. 101(3)
Leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) are cytokines which signal through receptor complexes that include the receptor subunits glycoprotein 130 (gp130) and the LIF receptor (LIFR), but CNTF also requires the non-sign
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c2e1e168eadd53ecdafd1ff0c0168269
https://pubmed.ncbi.nlm.nih.gov/17448148
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje